Tag Archives: Prometheus

Bristol-Myers Squibb v. Merck – Mayo/Alice Rule Reaches Medical Treatment Methods.

In Bristol-Myers Squibb v. Merck, Civil Action No. 150572-GMS (D. Del., 2016), Bristol-Myers sued Merck for inducing infringement of U.S. Pat. No. 9,073,994. Claim 1 reads: “A method of treating a metastatic melanoma comprising intravenously administering an effective amount of … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , | 3 Comments

USPTO Patent Eligibility Guidelines – A Step Too Far For Natural Products?

Guest Post from Paul Cole, Lucas & Co., UK New Prometheus/Myriad guidance appeared on the USPTO website on 4March under the weighty title 2014 Procedure For Subject Matter Eligibility Analysis Of Claims Reciting Or Involving Laws Of Nature/Natural Principles, Natural … Continue reading

Posted in Patentable Subject Matter, Uncategorized | Tagged , , , , , , , , , , , , | 1 Comment

PTO Releases Guidelines On Patenting “Natural Phenomena And Natural Products”

On March 4, 2014, Andrew Hirschfield, the Deputy Commissioner For Patent Examination Policy, released a “Memorandum” entitled “Guidance for Subject Matter Eligibility Analysis Of Claims Reciting Or Involving Laws of Nature/Natural Principles, Natural Phenomena, And/Or Natural Products” in view of … Continue reading

Posted in Patentable Subject Matter | Tagged , , , , , , , , , , , , , | Leave a comment

Patents at the Supreme Court: Update and Fallout

Warren Woessner and Charles R. Macedo will speak on patentable subject matter post-Myriad, Prometheus and CLS in the upcoming AUTM Webinar on September 12.  Warren (Schwegman Lundberg) will present on the patentability of life sciences’ inventions such as diagnostics, drug … Continue reading

Posted in Patentable Subject Matter, Webinar | Tagged , , , , , , , | Leave a comment